Press statement: Following the recent claim of a new treatment which can cure AIDS in the Gambia, UNAIDS and WHO strongly encourage the Gambia to collaborate with international experts on efforts to assess the safety, efficacy and quality of the therapeutic intervention, according to standard practices in any product development.

WHO, UNAIDS and UNICEF, guided by recent evidence, have agreed to modify as an interim the current recommendations (1) for cotrimoxazole prophylaxis in children. This is based upon recent trial data from Zambia (2).

The Joint United Nations Programme on HIV/AIDS (UNAIDS) welcomes a new collaborative initiative between the Government of Canada and the Bill & Melinda Gates Foundation to accelerate HIV vaccine research and development. The partnership entitled the ‘Canadian HIV Vaccine Initiative’ (CHVI) will contribute to the global effort to develop safe, effective, affordable and globally accessible HIV vaccines.

UNAIDS commends Merck’s decision to register ATRIPLA in developing countries. The registration of ATRIPLA, a once-daily single tablet regimen for treatment of HIV infection in adults, exemplifies the joint efforts of two research and development leaders, Merck Co. and Gilead Sciences to make essential medicines available to those in need.

UNAIDS mourns the death of french

The Joint United Nations Programme

Be smart – protect yourself”- The German football star and UNAIDS Special Representative Michael Ballack speaks out on HIV prevention by featuring in new public service announcement (PSA) on AIDS that urges young people to make smart choices.

The Joint United Nations Programme

One of Kenya’s leading scholars and renowned AIDS advocate and researcher, Professor Job Bwayo was killed during a shooting in the outskirts of Nairobi on Sunday 4 February.

A Phase III study of the candidate